News
16h
TipRanks on MSNBytes Technology Group Launches £25 Million Share Repurchase Programme
Bytes Technology Group Plc ( ($GB:BYIT) ) has shared an update. Bytes Technology Group plc has announced a share repurchase programme, aiming to ...
London, UK, 16 July 2013: BTG plc (LSE: BTG), the specialist healthcare company, today announces its interim management statement for the period from 1 April 2013 to 15 July 2013.
In its effort to accommodate the $4.2-billion colossal acquisition of BTG plc, Boston Scientific Corporation BSX is set to offload its certain non-prior businesses. The company has entered into an ...
BTG plc (LSE: BTG), a global specialist healthcare company, and the Society of Interventional Oncology (SIO), an international organisation working to nurture and support interventional oncology ...
BTG plc (LSE: BTG), the global specialist healthcare company, today announces it has acquired Novate Medical Ltd. (“Novate”), a medical device company ...
Boston Scientific today announced the completion of its acquisition of BTG plc. (LSE: BTG) pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used ...
LONDON, July 16, 2019 /PRNewswire/ -- BTG International Asia Limited, a subsidiary of BTG plc (LSE: BTG) announced today that it has agreed to invest RMB 76million (approximately USD 11million) in ...
IAN HARVEY is the Chief Executive Officer of BTG Plc. He has an MA in Mechanical Sciences from Cambridge University and an MBA from Harvard University. He was with Vickers and then Laporte ...
Boston Scientific Corporation (NYSE: BSX) Boston Scientific Announces Recommended Offer to Acquire BTG PLC November 20, 2018 7:15 AM ET Executives Susan Lisa - Vice President of Investor Relations ...
To bolster its offerings in interventional medicine, Boston Scientific agreed to purchase British device and pharma firm BTG PLC. for $4.24 billion in cash, according to The Wall Street Journal.
BTG plc is a UK pharmaceutical company specializing in antivenoms, oncology drugs and treatments for varicose veins. BTG's snakebite antivenom, Crofab, has been the most significant contributor to ...
MARLBOROUGH, Mass., Aug. 19, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of BTG plc.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results